Carregant...
Treatment and prognosis after progression in long-term responders to EGFR-tyrosine kinase inhibitor in advanced non-small cell lung cancer
INTRODUCTION: The aim of this study was to investigate the treatment and prognosis of advanced non-small cell lung cancer (NSCLC) patients after failure of long-term treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI). MATERIAL AND METHODS: We retrospectively analyze...
Guardat en:
| Publicat a: | Arch Med Sci |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Termedia Publishing House
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4754371/ https://ncbi.nlm.nih.gov/pubmed/26925125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2016.57586 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|